Certara’s Solid FY24 Performance and Cautious Outlook Lead to Hold Rating Despite Increased Price Target
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Certara (CERT – Research Report), boosting the price target to ...
Certara’s Strong Financial Performance and Strategic AI Positioning Drive Positive Outlook
In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Buy rating on Certara (CERT – Research Report), ...
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq ...
William Blair Brokers Raise Earnings Estimates for Certara
William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...
FY2024 Earnings Estimate for Certara Issued By William Blair
Stock analysts at William Blair increased their FY2024 earnings per share estimates for shares of Certara in a report issued on Wednesday, January 15th. William Blair analyst M. Smock now anticipates ...
bovnews4d
Certara Inc (CERT) Stock’s 0.07% Increase This Year: What’s the Story?
Certara Inc (CERT) stock saw a modest uptick, ending the day at $11.96 which represents a slight increase of $1.22 or 11.36% from the prior close of $10.74. The stock opened at $11.28 and touched a ...
Nasdaq5d
Certara, Inc. Reports Preliminary Full-Year 2024 Revenue of $384.4 Million and Bookings of $445.3 Million
Certara reports 2024 revenue of $384.4 million, bookings of $445.3 million, and confirms adjusted EBITDA guidance of $120-$124 million. Certara, Inc. reported preliminary financial results for ...
Morningstar6d
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced revenue and bookings for the fourth quarter and ...